Role of CDK5 in neuroprotection from serum deprivation by μ-opioid receptor agonist

Experimental Neurology

Volumn 202, Issue 2, 2006, Pages 313-323

  Wang, Ying ^a   Xie, Wei Yan ^a   He, Yi ^a   Wang, Min ^a   Yang, Yan Rui ^a   Zhang, Ying ^a   Yin, Dong Min ^a   Jordan Sciutto, Kelly L ^b   Han, Ji Sheng ^a   Wang, Yun ^a  

^a Neuroscience Research Institute   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Opioid agonist; Cyclin dependent kinase 5; Neuronal survival; Neuroprotection; p STAT3; p35; PI3K; Serum deprivation

Indexed keywords

CASPASE; CYCLIN DEPENDENT KINASE 5; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P35; SERINE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; HUMAN CELL; NERVE CELL; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYCLIN-DEPENDENT KINASE 5; DRUG INTERACTIONS; EMBRYO; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MUTAGENESIS; NALOXONE; NEURONS; NEUROPROTECTIVE AGENTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SERUM; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSFECTION;

EID: 33750626424     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.06.005     Document Type: Article

References (49)

1. Alexandre S., Rast C., Nguyen-Ba G., and Vasseur P. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in Syrian hamster embryo cells. Exp. Cell Res. 255 (2000) 30-39
2. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 (1991) 2499
3. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
4. Buchhalter J.R., and Dichter M.A. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus. Brain Res. Bull. 26 (1991) 333-338
5. Burow M.E., Weldon C.B., Melnik L.I., Duong B.N., Collins-Burow B.M., Beckman B.S., and McLachlan J.A. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem. Biophys. Res. Commun. 271 (2000) 342-345
6. Chergui K., Svenningsson P., and Greengard P. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2191-2196
7. Cheung Z.H., and Ip N.Y. Cdk5: mediator of neuronal death and survival. Neurosci. Lett. 361 (2004) 47-51
8. Cruz J.C., Tseng H.C., Goldman J.A., Shih H., and Tsai L.H. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40 (2003) 471-483
9. Datki Z., Juhasz A., Galfi M., Soos K., Papp R., Zadori D., and Penke B. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res. Bull. 62 (2003) 223-229
10. Fischer A., Sananbenesi F., Pang P.T., Lu B., and Tsai L.H. Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48 (2005) 825-838
11. Fu A.K., Fu W.Y., Ng A.K., Chien W.W., Ng Y.P., Wang J.H., and Ip N.Y. Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6728-6733 (electronic publication 2004 Apr 19)
12. Gross E.R., Hsu A.K., and Gross G.J. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ. Res. 94 (2004) 960-966
13. Hetman M., Kanning K., Cavanaugh J.E., and Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274 (1999) 22569-22580
14. Huang Y., Chan A.M., Liu Y., Wang X., and Holbrook N.J. Serum withdrawal and etoposide induce apoptosis in human lung carcinoma cell line A549 via distinct pathways. Apoptosis 2 (1997) 199-206
15. Humbert S., Dhavan R., and Tsai L. p39 activates CDK5 in neurons, and is associated with the actin cytoskeleton. J. Cell Sci. 113 Pt. 6 (2000) 975-983
16. Iglesias M., Segura M.F., Comella J.X., and Olmos G. Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 44 (2003) 482-492
17. Ino H., and Chiba T. Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm. Brain Res. 732 (1996) 179-185
18. Ivanov V.N., Krasilnikov M., and Ronai Z. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling. J. Biol. Chem. 277 (2002) 4932-4944
19. Jafari M.R., Zarrindast M.R., and Djahanguiri B. Effects of different doses of glucose and insulin on morphine state-dependent memory of passive avoidance in mice. Psychopharmacology (Berlin) 175 (2004) 457-462
20. Ji J.Z., Elyaman W., Yip H.K., Lee V.W., Yick L.W., Hugon J., and So K.F. CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur. J. Neurosci. 19 (2004) 265-272
21. Korsmeyer S.J. Regulators of cell death. Trends Genet. 11 (1995) 101-105
22. Kusakawa G., Saito T., Onuki R., Ishiguro K., Kishimoto T., and Hisanaga S. Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 275 (2000) 17166-17172
23. Lassus P., Ferlin M., Piette J., and Hibner U. Anti-apoptotic activity of low levels of wild-type p53. EMBO J. 15 (1996) 4566-4573
24. Lee J., Kim M.S., Park C., Jung E.B., Choi D.H., Kim T.Y., Moon S.K., and Park R. Morphine prevents glutamate-induced death of primary rat neonatal astrocytes through modulation of intracellular redox. Immunopharmacol. Immunotoxicol. 26 (2004) 17-28
25. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., and Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405 (2000) 360-364
26. Lew J., Huang Q.Q., Qi Z., Winkfein R.J., Aebersold R., Hunt T., and Wang J.H. A brain-specific activator of cyclin-dependent kinase 5. Nature 371 (1994) 423-426
27. Li B.S., Zhang L., Takahashi S., Ma W., Jaffe H., Kulkarni A.B., and Pant H.C. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21 (2002) 324-333
28. Li J., Lee J.M., and Johnson J.A. Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. J. Biol. Chem. 277 (2002) 388-394
29. Li B.S., Ma W., Jaffe H., Zheng Y., Takahashi S., Zhang L., Kulkarni A.B., and Pant H.C. CDK5 is involved in neuregulin-dependent activation of PI-3 kinase and Akt activity mediating neuronal survival. J. Biol. Chem. 278 (2003) 35702-35709
30. Lim Y.J., Zheng S., and Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 100 (2004) 562-668
31. Macleod M.R., Allsopp T.E., McLuckie J., and Kelly J.S. Serum withdrawal causes apoptosis in SHSY 5Y cells. Brain Res. 889 (2001) 308-315
32. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J., Baldwin Jr. A.S., and Mayo M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 20 (2000) 1626-1638
33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
34. Nguyen M.D., Mushynski W.E., and Julien J.P. Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ. 9 (2002) 1294-1306
35. Nikolic M., Chou M.M., Lu W., Mayer B.J., and Tsai L.H. The p35/CDK5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature (London) 395 (1998) 194-198
36. Noble W., Olm V., Takata K., Casey E., Mary O., Meyerson J., Gaynor K., LaFrancois J., Wang L., Kondo T., Davies P., Burns M., Nixon R., Dickson D., Matsuoka Y., Ahlijanian M., Lau L.F., and Duff K. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38 (2003) 555-565
37. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., and Tsai L.H. Conversion of p35 to p25 deregulates CDK5 activity and promotes neurodegeneration. Nature 402 (1999) 615-622
38. Porras A., Zuluaga S., Black E., Valladares A., Alvarez A.M., Ambrosino C., Benito M., and Nebreda A.R. P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell 15 (2004) 922-933
39. Sarkar F.H., Rahman K.M., and Li Y. Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. J. Nutr. 133 (2003) 2434S-2439S
40. Shen Y., Devgan G., Darnell Jr. J.E., and Bromberg J.F. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1543-1548
41. Stephanou A., Brar B., Liao Z., Scarabelli T., Knight R.A., and Latchman D.S. Distinct initiator caspases are required for the induction of apoptosis in cardiac myocytes during ischaemia versus reperfusion injury. Cell Death Differ. 8 (2001) 434-435
42. Tomizawa K., Sunada S., Lu Y.F., Oda Y., Kinuta M., Ohshima T., Saito T., Wei F.Y., Matsushita M., Li S.T., Tsutsui K., Hisanaga S., Mikoshiba K., Takei K., and Matsui H. Cophosphorylation of amphiphysin I and dynamin I by CDK5 regulates clathrin-mediated endocytosis of synaptic vesicles. J. Cell Biol. 163 (2003) 813-824
43. Tsai L.H., Delalle I., Caviness Jr. V.S., Chae T., and Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase. Nature 371 (1994) 419-423
44. Vogel M.W. Cell death, Bcl-2, Bax, and the cerebellum. Cerebellum 1 (2002) 277-287
45. Wang J., Liu S., Fu Y., Wang J.H., and Lu Y. CDK5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat. Neurosci. 6 (2003) 1039-1047
46. Yu V.C., and Sadee W. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J. Pharmacol. Exp. Ther. 245 (1988) 350-355
47. Zadina J.E., Harrison L.M., Ge L.J., Kastin A.J., and Chang S.L. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 270 (1994) 1086-1096
48. Zhang J., Krishnamurthy P.K., and Johnson G.V. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in Syrian hamster embryo cells. J. Neurochem. 81 (2002) 307-313
49. Zohar O., Getslev V., Miller A.L., Schreiber S., and Pick C.G. Morphine protects for head trauma induced cognitive deficits in mice. Neurosci. Lett. 394 (2006) 239-242